Table 3 Localisation of MM in frequent different primary tumours (more than 30 lesions per tumour)
From: Muscle metastases: comparison of features in different primary tumours
Primary tumours | Localisation, n (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
AWM | EoM | Glu | IP | HN | UE | PvM | Tho | LE | |
Lung cancer, LC (n = 162) | 4 (2.5) | 4 (2.5) vs BC p = 0.021 | 12 (7.4) vs EC p = 0.042 | 13 (8.0) | 1 (0.6) | 34 (21.0) vs BC p = 0.005 | 20 (12.3) | 24 (14.8) | 50 (30.9) vs BC p = 0.005 |
Colorectal carcinoma, CC (n = 48) | 7 (14.6) vs LC p = 0.021 | 1 (2.1) vs BC p = 0.021 | 7 (14.6) | 7 (14.6) | 1 (2.1) | 3 (6.3) | 8 (16.7) | 2 (4.2) | 12 (25.0) vs BC p = 0.009 |
Stomach cancer, SC (n = 33) | 1 (3.0) | 4 (12.1) vs BC p = 0.021 | 6 (18.2) | 2 (6.1) | 1 (3.0) | 1 (3.0) | 2 (6.1) | 3 (9.1) | 13 (39.4) vs BC p = 0.005 |
Esophageal cancer, EC (n = 46) | 2 (4.3) | 1 (2.2) vs BC p = 0.021 | 12 (26.1) vs BC p = 0.005 | 4 (8.7) | 4 (8.7) | 5 (10.9) | 3 (6.5) | 4 (8.7) | 11 (23.4) vs BC p = 0.018 |
Renal cell cancer, RCC (n = 46) | 4 (8.7) vs BC p = 0.021 | 3 (6.5) | 6 (13.0) | 2 (4.3) | 6 (13.0) | 5 (10.9) | 4 (8.7) | 16 (34.8) vs BC p = 0.005 | |
Urothel carcinoma, UC (n = 37) | 2 (5.4) | 4 (10.8) | 11 (29.7) vs BC p = 0.005 | 2 (5.4) | 3 (8.1) | 1 (2.7) | 14 (37.8) vs BC p = 0.005 | ||
Breast cancer, BC (n = 73) | 2 (2.7) | 53 (72.6) | 2 (2.7) | 1 (1.4) | 7 (9.6) vs BC p = 0.009 | 2 (2.7) | 3 (4.1) | 3 (4.1) | |